Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,007 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct-acting antiviral agents.
Ohama H, Hiraoka A, Tada T, Kariyama K, Itobayashi E, Tsuji K, Ishikawa T, Toyoda H, Hatanaka T, Kakizaki S, Naganuma A, Tada F, Tanaka H, Nakamura S, Nouso K, Tanaka K, Kumada T; Real‐life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Ohama H, et al. Among authors: tanaka k, tanaka h. J Gastroenterol Hepatol. 2024 Apr 11. doi: 10.1111/jgh.16553. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38602340
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma.
Tomonari T, Sato Y, Tanaka H, Mitsuhashi T, Hirao A, Tanaka T, Taniguchi T, Okamoto K, Sogabe M, Miyamoto H, Muguruma N, Takayama T. Tomonari T, et al. Among authors: tanaka t, tanaka h. JGH Open. 2021 Oct 22;5(11):1275-1283. doi: 10.1002/jgh3.12663. eCollection 2021 Nov. JGH Open. 2021. PMID: 34816013 Free PMC article.
Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma.
Tomonari T, Tani J, Ogawa C, Deguchi A, Senoh T, Moriya A, Shibata H, Fukuno H, Tanaka H, Tanaka T, Taniguchi T, Sogabe M, Kawano Y, Morishita A, Takaguchi K, Miyamoto H, Sato Y, Masaki T, Takayama T. Tomonari T, et al. Among authors: tanaka t, tanaka h. Hepatol Res. 2023 Feb;53(2):172-178. doi: 10.1111/hepr.13845. Epub 2022 Oct 18. Hepatol Res. 2023. PMID: 36214071
Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
Sogabe M, Okahisa T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Kawano Y, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: tanaka h. J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38419514
A case of complete response with rechallenge-lenvatinib plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma refractory to multiple molecular-targeted agent treatments.
Tomonari T, Tanaka H, Tanaka T, Taniguchi T, Sogabe M, Kawano Y, Okamoto K, Miyamoto H, Sato Y, Takayama T. Tomonari T, et al. Among authors: tanaka t, tanaka h. Clin J Gastroenterol. 2023 Jun;16(3):438-443. doi: 10.1007/s12328-023-01777-y. Epub 2023 Mar 1. Clin J Gastroenterol. 2023. PMID: 36856957
Initial therapeutic results of atezolizumab plus bevacizumab for unresectable advanced hepatocellular carcinoma and the importance of hepatic functional reserve.
Tomonari T, Tani J, Sato Y, Tanaka H, Tanaka T, Taniguchi T, Asahiro M, Okamoto K, Sogabe M, Miyamoto H, Muguruma N, Masaki T, Takayama T. Tomonari T, et al. Among authors: tanaka t, tanaka h. Cancer Med. 2023 Feb;12(3):2646-2657. doi: 10.1002/cam4.5145. Epub 2022 Aug 14. Cancer Med. 2023. PMID: 35964253 Free PMC article.
Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Tomonari T, Kawano Y, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: tanaka h. Eur J Clin Invest. 2024 Apr 18:e14221. doi: 10.1111/eci.14221. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38634705
15,007 results
You have reached the last available page of results. Please see the User Guide for more information.